Virtual Reality Use in Assisted Reproductive Technology

Launched by DR CLIFF LIBRACH · May 14, 2020

Keywords

ClinConnect Summary

In vitro fertilization (IVF) treatment involving ovarian stimulation, oocyte retrieval and embryo transfer (ET) is an effective treatment for various causes of infertility. Despite advances in ovarian stimulation regimens and laboratory conditions, many IVF cycles do not result in pregnancy, and repeated treatment cycles are required. According to the latest Assisted reproductive technology (ART) surveillance report in the United states, of 143,286 procedures that progressed to the ET stage, 50.9% resulted in a pregnancy and 41.4% in a live-birth. Achieving higher pregnancy and live birth r...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 21-45-year-old female patients, if using own ovum. Patients above this age range may be approached for study if using a donated ovum, as long as "egg age" (age of donor at ovum pick up) falls in 21-45 age range.
• • Undergoing frozen ET procedures, and approached for study on "Day 2 - Day 4" of ET transfer cycle.
• • Ability to provide written consent to use VR technology before the ET procedure
• Exclusion Criteria:
• • Contraindication to use VR technology (Epilepsy/previous seizure, claustrophobia, current migraine, heart disease, visual and/or auditory deficits/use of medical devices such as cardiac pacemaker or hearing aids)
• • Anxiety disorder and/or Regular use of anti-anxiety medications
• • Major uterine anomalies and/or uterine fibroids distorting the cavity